This study is testing whether adding an experimental anti-inflammatory drug called NT-0796 to the weight-loss medication semaglutide can help people with obesity lose more weight and reduce inflammation. About 82 adults with a BMI of 30 to 45 will take either the combination or a…
Phase: PHASE2 • Sponsor: NodThera Limited • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC